Screener / SEC EDGAR /CIK 0001321732 /10-K filed Feb 25, 2026, compared with Feb 18, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Medical Instruments

Penumbra Inc PEN

Compare with peers Embed
Planned sales, announced before they happen

1 trading plan running, 7 Form 144 notices for $10.0M

10-Q, 10-K and Form 144

What PEN's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Nov 27, 2024 to Nov 30, 2026. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Arani Bose
Director
Ended 10b5-1 plan Feb 6, 2026 10-Q May 6, 2026
Bridget O'Rourke
Director
Ended 10b5-1 plan Jan 23, 2026 10-Q May 6, 2026
Adam Elsesser
Chairman and Chief Executive Officer
Ended 10b5-1 plan Jan 22, 2026 10-Q May 6, 2026
Johanna Roberts
Executive Vice President, General Counsel and Secretary
Ended 10b5-1 plan Jan 22, 2026 10-Q May 6, 2026
Maggie Yuen
Chief Financial Officer
Adopted 10b5-1 plan Nov 24, 2025 10-K Feb 25, 2026
Arani Bose
Director
Adopted 10b5-1 plan Nov 17, 2025 10-K Feb 25, 2026
Bridget O'Rourke
Director
Adopted 10b5-1 plan Nov 12, 2025 10-K Feb 25, 2026
Adam Elsesser
Chairman and Chief Executive Officer
Adopted 10b5-1 plan Nov 10, 2025 10-K Feb 25, 2026
Johanna Roberts
Executive Vice President, General Counsel and Secretary
Adopted 10b5-1 plan Nov 10, 2025 10-K Feb 25, 2026
Harpreet Grewal
Director
Adopted 10b5-1 plan May 28, 2025 10-Q Jul 29, 2025
Arani Bose
Director
Adopted 10b5-1 plan May 23, 2025 10-Q Jul 29, 2025
Thomas Wilder
Director
Adopted 10b5-1 plan May 13, 2025 10-Q Jul 29, 2025
Maggie Yuen
Chief Financial Officer
Adopted 10b5-1 plan Nov 29, 2024 10-K Feb 18, 2025
Lambert Shiu
Chief Accounting Officer
Adopted 10b5-1 plan Nov 27, 2024 10-K Feb 18, 2025
Johanna Roberts
Executive Vice President, General Counsel and Secretary
Adopted 10b5-1 plan Nov 26, 2024 10-K Feb 18, 2025
Adam Elsesser
Chairman, Chief Executive Officer and President
Adopted 10b5-1 plan Nov 25, 2024 10-K Feb 18, 2025
Arani Bose
Director
Adopted 10b5-1 plan Nov 21, 2024 10-K Feb 18, 2025
Thomas Wilder
Director
Adopted 10b5-1 plan Nov 14, 2024 10-K Feb 18, 2025
Bridget O'Rourke
Director
Adopted 10b5-1 plan Nov 11, 2024 10-K Feb 18, 2025
Don Kassing
Director
Adopted 10b5-1 plan Nov 4, 2024 10-K Feb 18, 2025
Lambert Shiu
Chief Accounting Officer
Adopted 10b5-1 plan Aug 29, 2024 10-Q Oct 30, 2024
Arani Bose
Director
Adopted 10b5-1 plan May 14, 2024 10-Q Jul 30, 2024
Harpreet Grewal
Director
Adopted 10b5-1 plan May 14, 2024 10-Q Jul 30, 2024
Adam Elsesser
Chairman, Chief Executive Officer and President
Adopted 10b5-1 plan Nov 29, 2023 10-K Feb 22, 2024
Johanna Roberts
Executive Vice President, General Counsel and Secretary
Adopted 10b5-1 plan Nov 29, 2023 10-K Feb 22, 2024
Arani Bose
Director
Adopted 10b5-1 plan Nov 22, 2023 10-K Feb 22, 2024
Don Kassing
Director
Adopted 10b5-1 plan Nov 8, 2023 10-K Feb 22, 2024
Thomas Wilder
Director
Adopted plan Nov 8, 2023 10-K Feb 22, 2024
Lambert Shiu
Chief Accounting Officer
Adopted plan Nov 7, 2023 10-K Feb 22, 2024
Lambert Shiu
Chief Accounting Officer
Adopted plan Aug 31, 2023 10-Q Nov 2, 2023
Thomas Wilder
Director
Ended plan Aug 14, 2023 10-Q Nov 2, 2023
Harpreet Grewal
Director
Adopted plan May 23, 2023 10-Q Aug 1, 2023
Bridget O'Rourke
Director
Adopted plan May 22, 2023 10-Q Aug 1, 2023
Arani Bose
Director
Adopted plan May 19, 2023 10-Q Aug 1, 2023
Surbhi Sarna
Director
Adopted plan May 18, 2023 10-Q Aug 1, 2023
Maggie Yuen
Chief Financial Officer
Adopted plan May 16, 2023 10-Q Aug 1, 2023
Don Kassing
Director
Adopted plan May 9, 2023 10-Q Aug 1, 2023
Thomas Wilder
Director
Adopted plan May 8, 2023 10-Q Aug 1, 2023
Show the other 30 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 2, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Apr 2, 2026 Grewal Harpreet
Director
100 $33K
Mar 2, 2026 MAGGIE YUEN
Officer
2,432 $832K
Jan 6, 2026 Grewal Harpreet
Director
186 $58K
Jan 2, 2026 THOMAS WILDER
Director
186 $58K
Dec 2, 2025 Grewal Harpreet
Director
100 $29K
Nov 25, 2025 Johanna Roberts
Officer
2,100 $626K
Nov 21, 2025 Arani Bose
Affiliate
30,000 $8.4M

From the Form 144 XML filed with the SEC, since Nov 21, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PEN/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.